Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - GROSS PROFIT
Gross Profit KPTI - Karyopharm Therapeutics Inc.
139 M
LAST VALUE
-4.25%
2 YEAR CAGR
29.33%
5 YEAR CAGR
15.77%
10 YEAR CAGR